Patents by Inventor Michael C. Wiemann

Michael C. Wiemann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Reduction of the severity of 3'-azido-3'-deoxythymidine-induced anemia using a combination of benzylacyclouridine and dipyridamole
    Patent number: 4950466
    Abstract: The invention is directed to a method of inhibiting anemia caused by the administration of AZT to a patient which comprises administering to said patient an effective anemia-inhibiting amount of a combination of dipyridamole and 5-benzylacyclouridine. The invention is further directed to a pharmaceutical composition comprising as the active pharmaceutical agent a combination of dipyridamole and 5-benzylacyclouridine in association with a pharmaceutically acceptable carrier or diluent.
    Type: Grant
    Filed: June 22, 1988
    Date of Patent: August 21, 1990
    Inventors: Paul Calabresi, James W. Darnowski, Michael C. Wiemann
  • Reduction of the severity 3'-azido-3'-deoxythymidine-induced anemia using benzylacyclouridine
    Patent number: 4874602
    Abstract: A method of reducing anemia caused by the administration of 3'-azido-3'-deoxythymidine to an animal which comprises treating said animal with a compound which inhibits the enzyme uridine phosphorylase in order to increase cellular uridine levels is disclosed. A particularly-effective compound is 5-benzylacyclouridine.
    Type: Grant
    Filed: February 22, 1988
    Date of Patent: October 17, 1989
    Inventors: Paul Calabresi, Michael C. Wiemann, Ming Y. W. Chu